85-1541-46 RAGE, Recombinant, Canine (Receptor for Advanced Glycosylation End Products, Advanced Glycosylation End Product-specific Receptor, AGER) 50ug R1031-15C

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Advanced glycation endproducts (AGEs) are adducts formed by the nonenzymatic glycation of macromolecules. AGE formation is accelerated in oxidative and hyperglycemic conditions, diabetes, renal failure, atherosclerosis, Alzheimer’s disease, arthritis, and in normal aging (1-5). Receptor for advanced glycation endproducts (RAGE) is a 35kD type I transmembrane protein belonging the immunoglobulin superfamily. Besides AGEs, RAGE binds b-amyloid peptide, S100/calgranulin family proteins, HMGB1/amphoterin, and leukocyte integrins (6-9). Mature canine RAGE consists of a 383 amino acid (aa) extracellular domain (ECD) with one Ig-like V-type domain and two Ig-like C-type domains, a 23 aa transmembrane segment, and a 43 aa cytoplasmic domain (10). Within the ECD, canine RAGE shares 73%-77% aa sequence identity with human, mouse, and rat RAGE. In human, soluble forms of RAGE are generated by alternate splicing and are associated with multiple disease states (11, 12). RAGE is expressed in the embryonic central nervous system and on macrophages, monocytes, smooth muscle cells, and endothelial cells (13-15). It is upregulated in response to AGE accumulation, and its activation induces a broad proinflammatory response (6, 15). The increased production of reactive oxygen species during inflammation promotes additional AGE formation and RAGE upregulation, a cycle that exacerbates diabetic complications and inflammation-induced tissue injury (2, 4).
  • A DNA sequence encoding the extracellular domain of canine RAGE (Met 1-Val 339; Accession # ABA18645) was fused to a six-histidine tag at the C-terminus in a mouse myeloma cell line, NS0.
  • Calculated molecular mass of 34.6kD. The recombinant canine RAGE migrates as an ~40-44kD protein in SDS-PAGE under reducing conditions.
  • Activity: Measured by its ability to bind biotinylated advanced glycation endproducts of bovine serum albumin (AGE-BSA)
  • Storage and Stability:Lyophilized powder may be stored at 4°C for short-term only. Reconstitute to nominal volume by adding sterile PBS and store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

  • Size:50ug
  • Source Antigen:Recombinant Canine
  • Grade:Highly Purified
  • Purity:≥ 90%, as determined by SDS-PAGE under reducing conditions and visualized by silver stain.Endotoxin: ≤ 1EU/1ug.
  • Form:Supplied as a lyophilized powder in PBS. Reconstitute with PBS to ≥100ug/ml.
  • Molecular Weight Non Ab:34.6
  • EU Commodity Code:30021019
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-1541-46
型番
R1031-15C
入り数
1個
標準価格
261,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る